Topic

Washington

A collection of 516 issues

How to Get Mepsevii (vestronidase alfa-vjbk) Covered by Aetna (CVS Health) in Washington: Prior Authorization Guide and Appeals Process

Answer Box: Getting Mepsevii Covered by Aetna (CVS Health) in Washington Mepsevii (vestronidase alfa-vjbk) requires prior authorization from Aetna (CVS Health), with strict criteria including confirmed MPS VII diagnosis via enzyme assay or genetic testing, specialist prescription, and elevated urinary glycosaminoglycans. Submit the Aetna Mepsevii precertification form with complete documentation.
6 min read

How to Get Epidiolex (Cannabidiol) Covered by Humana in Washington: Prior Authorization Guide and Appeal Process

Answer Box: Getting Epidiolex Covered by Humana in Washington Epidiolex requires prior authorization from Humana for all FDA-approved seizure disorders (Lennox-Gastaut syndrome, Dravet syndrome, tuberous sclerosis complex). The fastest path to approval: 1. Confirm diagnosis with ICD-10 code and specialist consultation 2. Document failed antiseizure medications or contraindications 3. Submit
5 min read

How to Get Tysabri (Natalizumab) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tysabri Covered by Blue Cross Blue Shield in Washington Tysabri (natalizumab) requires prior authorization from all Blue Cross Blue Shield plans in Washington. The fastest path to approval: (1) Ensure TOUCH program enrollment for both patient and prescriber, (2) Submit comprehensive prior authorization with MRI documentation and
6 min read

How to Get Tepezza (teprotumumab) Covered by Cigna in Washington: Prior Authorization, Appeals, and Billing Guide

Quick Answer: Tepezza (teprotumumab) requires prior authorization through Cigna's Express Scripts/Accredo specialty pharmacy network. Submit clinical documentation including TED diagnosis (ICD-10: E05.00), disease severity assessment, and weight-based dosing justification. If denied, Washington residents can appeal through internal review, then external IRO review within 60 days. Start
6 min read

Renewing Xospata (Gilteritinib) Approval with UnitedHealthcare in Washington: Timeline, Documentation, and Appeal Guide

Answer Box: Renewing Xospata Coverage with UnitedHealthcare in Washington To renew Xospata (gilteritinib) approval with UnitedHealthcare in Washington, start the process 30 days before your current authorization expires. Submit updated FLT3 mutation testing, treatment response documentation, and current lab results through the OptumRx provider portal. If denied, you can appeal
5 min read

Lowering Out-of-Pocket Costs for Signifor LAR (Pasireotide) with UnitedHealthcare in Washington: Complete Guide to Copay Assistance, Tier Exceptions, and Appeals

Quick Answer: Lowering Your Signifor LAR Costs Signifor LAR (pasireotide) is a high-cost specialty medication typically placed on Tier 4-5 with UnitedHealthcare, meaning significant out-of-pocket costs. However, multiple cost-reduction strategies exist: 1. Apply for the Recordati copay card (commercial insurance only) - reduces copays to $20 for eligible patients 2.
6 min read